AI assistant
Precise Biometrics — Interim / Quarterly Report 2010
Jul 20, 2010
3189_ir_2010-07-20_9fcb4e76-70c4-4dab-88c7-6905e6f90e6f.pdf
Interim / Quarterly Report
Open in viewerOpens in your device viewer
Page 1 of 15
IMPROVED RESULT – DESPITE LOWER SALES
Precise Biometrics AB (publ), Corporate Identity No. 556545-6596 Interim Report for the period January – June 2010
- The group's net sales for the interim period amounted to SEK 26.4 million (21.9) and for the second quarter SEK 7.1 million (9.7).
- The group's income for the interim period amounted to SEK ‐5.1 million (‐11.6) and for the second quarter SEK ‐4.7 million (‐9.0).
- Earnings per share for the interim period amounted to SEK ‐0.04 (‐0.11) and for the second quarter SEK ‐0.04 (‐0.09).
- Liquid assets at the end of the interim period amounted to SEK 34.8 million (1.5).
Important events during the quarter
- Precise Biometrics released the product Precise BioMatch™ ANSI 378, an integration tool for standardized fingerprint recognition for both PC and Mac. The technology uses Precise Biometrics' fingerprint extractor which was top ranked in Ongoing MINEX.
- Precise Biometrics released Precise BioMatch™ Logon for Windows 7, a biometric logon solution for Microsoft's new operating system Windows 7.
For further information Thomas Marschall, President and CEO, Precise Biometrics AB Tel. +46 (0)46 31 11 10 or +46 (0)734 35 11 10 E-mail [email protected]
Patrik Norberg, CFO, Precise Biometrics AB Tel. +46 46 31 11 47 or +46 734 35 11 47 E-mail [email protected]
Precise Biometrics is a market-leading provider of products and solutions for fingerprint recognition. The technology proves people's identities in a fast and secure way, while it reduces costs related to password management, identity theft and fraud.
Precise Biometrics serves business and government organizations throughout the world and its technology is licensed to close to 100 million users. Precise Biometrics is listed on NASDAQ OMX Stockholm small cap list (PREC).
For more information, please visit www.precisebiometrics.com or view the Company presentation.
Improved result – despite lower sales ‐ Interview with the President & CEO, Thomas Marschall
What are your comments on the last quarter?
Sales for the quarter were lower than the same period last year. Considering the number of business opportunities we work on, not being able to present a larger number of orders during the quarter is not satisfactory. At the same time, I am pleased with our continuous efforts in cost control. This enables us to present a result that has improved compared to the same period in 2009 despite the lower sales volume.
How would you summarize the first half of 2010?
Sales during the first half of 2010 were at about the same level as the same period last year. The activity level on the market picked up in the spring and we are currently working with several interesting sales projects. We are also in negotiations regarding significant commercial partnerships. Because of turbulence in the capital markets, that has intensified during the second quarter, decision‐making on investments has taken more time with effect that resolutions of projects has been shifted into the second half of the year. However, I think the state of the market is becoming increasingly positive and that Precise Biometrics' market is on the rise.
How far have you come with the organizational change?
Our new organization has now been implemented as of July 1st. As part of the change, we are also strengthening our sales organization through new recruitment. The new organization is more customer‐oriented than before and focuses on packaging and marketing our world‐ leading technology in a manner that solves complex problems for our customers.
Do you have any comments on standardization of biometrics?
The standardization process that is underway is based on different elements of the technology and its usage being made uniform in accordance with an international standard. This facilitates interoperability between different suppliers.
Standardization is positive since it shows both that the technology has reached a level of maturity that makes the world ready to use it and that there is an expressed need. With our leading global position, we have the best opportunities in the market to capitalize on this acceptance.
What do you think about the company's financial position?
We have a good financial position with a strong cash balance. An increasing number of running orders from existing customers combined with lower costs gives Precise Biometrics good staying power and allows us to be on the offensive in our marketing activities.
Page 3 of 15 Lund, July 20, 2010
How would you summarize the current situation?
The business plan we adopted for the next 5 years is ambitious and opportunities in all market segments have continued to grow in a positive direction over the last six months. As I indicated previously – most recently in the last quarterly report – we are still dependent on the timing of individual orders. This causes sales figures to fluctuate between different quarters. To make a meaningful assessment of the companyʹs development, it is therefore necessary to look at the full year developments rather than shifts between specific quarters.
Sales and result
Interim period; January to June 2010
Sales for the interim period amounted to SEK 26.4 million (21.9). The gross profit was SEK 16.4 million (14.3). The gross margin amounted to 62 % compared to 65 % the same period the previous year. The group's net loss for the interim period improved to SEK ‐5.1 million (‐11.6). The result has been affected by an exchange rate gain of SEK 1.8 million. Operating expenses (see Key Figures for definition) for the interim period were reduced to SEK 21.4 million (25.6). Losses per share (average number of shares) for the interim period amounted to SEK ‐0.04 (‐ 0.11).
Second quarter; April to June 2010
Sales for the second quarter was SEK 7.1 million (9.7). The gross margin improved to 69% (60%). The Group's net loss for the second quarter improved to SEK ‐4.7 million (‐9.0). The result has been affected by an exchange rate gain of SEK 1.7 million. Operating costs (see Key Figures for definition) were reduced to SEK 9.6 million (14.8). Losses per share (average number of shares) for the second quarter amounted to SEK ‐0.04 (‐0.09).
Financing and liquidity
Equity amounted as of June 30, 2010 to SEK 39.8 million (4.4) and equity/share to SEK 0.29 (0.04).
Cash flow from current operations amounted to SEK 0.2 million (‐8.5). Liquid assets at the end of the interim period amounted to SEK 34.8 million (1.5).
Market and sales – Q2 2010
The majority of sales in Precise Biometrics for the first six months of 2010 were mainly based on a combination of fingerprint readers and sales of licenses to existing customers.
The new sales organization came into force on 1 July and during the remainder of the year the new business areas will be focusing on building up their activities and creating a stable platform for earnings during the latter part of the year and going forward.
During the second quarter Precise Biometrics released several new products for integration of fingerprint recognition. These new products include Precise BioMatch™ ANSI 378, an integration tool for the development of solutions based on standardized fingerprint technology. ANSI 378 has been specified by the US authorities for the PIV card they issue to all their employees. At the end of the quarter Precise Biometrics also released products to integrate ISO‐ standardized Match‐on‐Card. In that both these products are based on standards it will be easier for customers and integrators to choose between different suppliers, and therefore achieve greater flexibility and compatibility in their solutions.
In the last few years Precise Biometrics has participated in several EU‐financed development projects where there are synergies with the Company's own research ambitions. These projects include MEDEA+ ONOM@TOPIC+. This project won the prestigious EUREKA Innovation Award in June, which confirms the innovative excellence of the project and its tangible applications. The project was led by Gemalto for the objective of creating advanced solutions for eID and contactless mobile applications.
Page 5 of 15
Lund, July 20, 2010
Parent company
Parent company sales for the interim period amounted to SEK 22.5 million (16.8). Operating loss before tax for the interim period amounted to SEK ‐3.1 million (‐9.4).
At the end of the interim period 23 persons were employed in the parent company.
Liquid assets at the end of the second quarter amounted to SEK 32.3 million (1.4). The parent company had no debts to credit institutions at the end of the second quarter.
Organization and staff
The parent company of Precise Biometrics has its head office in Lund, Sweden. The organization also consists of the subsidiaries Precise Biometrics Inc. in Washington DC, USA, and Precise Biometrics Solutions AB with office in Karlstad. The subsidiary in Asia, Precise Biometrics Asia Ltd., will close during 2010. The organization also includes the dormant companies Precise Biometrics Services AB and Loqware Sweden AB (in the process of liquidation).
As of June 30, 2010 the group had 33 (35) employees, 32 in Sweden and 1 in the US. Of these employees, 23 (26) were men and 10 (9) were women.
Investments in tangible fixed assets
No investments in tangible fixed assets were made in the first half of the year.
Capitalization and depreciation of development work
Development work costs of SEK 1.5 million (0.6) were capitalized during the interim period. Depreciation of capitalized costs for development work amounted to SEK 0.8 million (0.7) during the interim period.
During the second quarter development costs of SEK 0.9 million (0.3) were capitalized. Depreciation of capitalized development costs amounted to SEK 0.4 million (0.4) during the quarter.
Patents
The group's long‐term patent strategy focuses on establishing a strong protection around Precise Match‐on‐Card™ as our core technology. The patents portfolio has been successively improved since 2001 and at the end of the second quarter in 2010 included 74 registered patents and 32 applications for patents in 21 different product families. Precise Biometrics has 13 different patent families just for the Match‐on‐Card technology.
Annual General Meeting
Precise Biometrics Annual General Meeting 2010 was held on April 21 2010 in Precise Biometricsʹ headquarters in Lund.
In accordance with the recommendations of the board of directors, the stockholder's meeting resolved to authorize a new issue to a maximum of SEK 5.4 million, or 13.5 million shares, with a provision for issue against subscription in kind. The purpose of the authorization was to enable the company to effect payment of company acquisitions by the company's own shares and/or convertibles.
Page 6 of 15 Lund, July 20, 2010
Marc Chatel, Torbjörn Clementz, Eva Maria Matell, Lisa Thorsted and Lena Widin Klasén were re‐elected as members of the board and Lisa Thorsted was re‐elected chairman of the Board.
Shares
The company's share is listed on the Small Cap list of the Nasdaq OMX Nordic.
The total number of registered shares at the end of the quarter was 134,960,800. During the interim period the average turnover per day was SEK 2,182 thousand and the list price ranged from SEK 2.58 to 1.54. During the second quarter the average turnover per day was SEK 1,133 thousand and the list price ranged from SEK 2.45 to 1.54.
The main shareholders as of June 30, 2010
| Name | Percentage of share capital | No. of shares | |
|---|---|---|---|
| Avanza Pension Försäkring | 6.3% | 8,344,793 | |
| Swedbank Robur fonder | 3.9% | 5,315,932 | |
| Stockpicker fonder | 3.9% | 5,234,878 | |
| Nordnet Pensionsförsäkring | 1.7% | 2,289,311 | |
| Source: SIS Ägarservice |
Risk factors
Precise Biometrics is exposed to both commercial and financial risks, which to a large extent lie outside the reach and influence of the company. For a full account of identified risks, please refer to the Annual Report for 2009, which was submitted April 1, 2010. No further essential risks or uncertainties have arisen after the submission of the Annual Report.
| Future report dates | |
|---|---|
| Interim Report Q3 | October 21, 2010 |
| Year‐end Report | February 4, 2011 |
Accounting principles
This interim report has been prepared in accordance with IAS 34, Interim reporting and the Swedish Company Accounts Act.
New IFRS, additions to IAS and IFRIC interpretations taking effect January 1, 2010, will not have a material effect on the financial statements.
For information on the applied accounting principles please refer to the Annual Report for 2009.
This quarterly report has not been subjected to review by the Company's auditors.
Lund, July 19, 2010
The Board of Directors and the President certify that the interim report gives a true and fair overview of the parent companyʹs and groupʹs operations, their financial position and results of
Page 7 of 15
Lund, July 20, 2010
operations, and describes significant risks and uncertainties facing the parent company and other companies in the group.
The board of directors
Lisa Thorsted, chairman
Marc Chatel Lena Widin Klasén Eva Maria Matell Torbjörn Clementz
Thomas Marschall, President and CEO
Income statement, Group
| (Figures in thousands SEK) | Q2 | Q2 | Q1-Q2 | Q1-Q2 | Full year |
|---|---|---|---|---|---|
| 2010 | 2009 | 2010 | 2009 | 2009 | |
| Net sales | 7,149 | 9,747 | 26,429 | 21,943 | 68,655 |
| Cost of goods sold | -2,238 | -3,903 | -10,005 | -7,663 | -32,863 |
| Gross profit/loss | 4,911 | 5,844 | 16,424 | 14,280 | 35,792 |
| Selling expenses | -5,050 | -7,240 | -9,236 | -12,567 | -30,445 |
| Administrative expenses | -2,266 | -3,806 | -5,267 | -6,800 | -12,554 |
| R&D costs | -3,995 | -2,988 | -8,665 | -6,496 | -12,092 |
| Other operating income and changes in value | 1,668 | -724 | 1,780 | 266 | -977 |
| -9,643 | -14,758 | -21,388 | -25,597 | -56,068 | |
| Operating profit/loss | -4,732 | -8,914 | -4,964 | -11,317 | -20,276 |
| Financial costs | -16 | -131 | -114 | -309 | -1,492 |
| Profit/loss after financial items | -4,748 | -9,045 | -5,078 | -11,626 | -21,768 |
| Tax | - | - | - | - | -4 |
| Profit/loss for the period | -4,748 | -9,045 | -5,078 | -11,626 | -21,772 |
| Profit/loss attributable to: | |||||
| Owners of the parent | -4,748 | -9,045 | -5,078 | -11,626 | -21,772 |
| Results per share, SEK | -0.04 | -0.09 | -0.04 | -0.11 | -0.19 |
Page 9 of 15
Lund, July 20, 2010
Comprehensive income, Group
(according to IAS 1)
| (Figures in thousands SEK) | Q2 | Q2 | Q1-Q2 | Q1-Q2 | Full year |
|---|---|---|---|---|---|
| 2010 | 2009 | 2010 | 2009 | 2009 | |
| Change in accumulated exchange rate differences |
-584 | 660 | -580 | 65 | 621 |
| Comprehensive income for the period, net of tax |
-584 | 660 | -580 | 65 | 621 |
| Profit/loss for the period Total comprehensive income for the |
-4,748 | -9,045 | -5,078 | -11,626 | -21,772 |
| period | -5,332 | -8,385 | -5,658 | -11,561 | -21,151 |
| Total comprehensive income attributable to: |
|||||
| Owners of the parent | -5,332 | -8,385 | -5,658 | -11,561 | -21,151 |
Balance Sheet, Group
| (Figures in thousands SEK) | 6/30/2010 | 6/30/2009 | 12/31/2009 |
|---|---|---|---|
| Assets | |||
| Intangible fixed assets | 4,562 | 9,148 | 3,802 |
| Tangible fixed assets | 701 | 1,048 | 868 |
| Inventories | 4,578 | 5,987 | 6,047 |
| Accounts receivable - trade | 6,909 | 6,996 | 16,758 |
| Other current receivables | 4,699 | 3,566 | 4,734 |
| Cash and bank balances | 34,780 | 1,520 | 40,884 |
| Total assets | 56,229 | 28,265 | 73,093 |
| Equity and liabilities | |||
| Equity | 39,750 | 4,366 | 45,408 |
| Current liabilities | 16,479 | 23,899 | 27,685 |
| Total equity and liabilities | 56,229 | 28,265 | 73,093 |
| Pledged assets | 23,400 | 17,400 | 26,400 |
| Contingent liabilities | - | - | - |
Cash Flow Statement, Group
| (Figures in thousands SEK) | Q2 | Q2 | Q1-Q2 | Q1-Q2 Full year | |
|---|---|---|---|---|---|
| 2010 | 2009 | 2010 | 2009 | 2009 | |
| Cash flow from operating activities | |||||
| before changes in working capital | -5,026 | -7,820 | -5,076 | -10,520 | -14,276 |
| Cash flow from changes in working capital | 5,177 | -729 | 528 | -4,569 | -6,931 |
| Cash flow from operating activities | 151 | -8,549 | -4,548 | -15,089 | -21,207 |
| Cash flow from investing activities | -868 | -379 | -1,556 | -657 | -1,299 |
| Cash flow from financing activities | 0 | 6,000 | 0 | 5,923 | 52,047 |
| Cash flow for the period | -717 | -2,928 | -6,104 | -9,823 | 29,541 |
| Liquid funds at the beginning of the period | 35,497 | 4,448 | 40,884 | 11,343 | 11,343 |
| Liquid funds at the end of the period | 34,780 | 1,520 | 34,780 | 1,520 | 40,884 |
Key Figures, Group
| 6/30/2010 | 6/30/2009 | 12/31/2009 | ||
|---|---|---|---|---|
| Working capital (thousands SEK) | 34,487 | -5,830 | 40,738 | |
| Liquid ratio | 281% | 51% | 225% | |
| Equity/assets ratio | 71% | 15% | 62% | |
| Return on average equity | - | - | neg | |
| Capital employed (thousands SEK) | 41,149 | 4,366 | 46,900 | |
| Return on capital employed | - | - | neg | |
| Profit/loss per share (SEK) | -0.04 | -0.11 | -0.19 | |
| EBITDA (thousands SEK) | -4,001 | -9,871 | -12,662 | |
| Equity per share (SEK) | 0.29 | 0.04 | 0.34 | |
| Number of shares | 134,960,800 | 101,220,600 | 134,960,800 | |
| Number of employees at the end of the period |
33 | 35 | 36 | |
| Average number of employees during the | ||||
| period | 34 | 41 | 38 |
Definitions - Key Figures
Working capital: Current assets less current liabilities
Liquid ratio: Current assets less inventories divided by current liabilities
Equity/assets ratio: Equity as of the balance sheet date divided by total assets as of the balance sheet date
Return on equity: Profit/loss for the period divided by average equity
Capital employed: Balance sheet total minus non-interest-bearing liabilities and provisions
Return on capital employed: Profit/loss after financial items plus financial expenses divided by the average capital employed
Profit/loss per share: Profit/loss after tax divided by the average number of shares. The options are not included in the calculation due to calculation of potential shares would result in an improvement in loss per share which is not permitted according to IAS 33
EBITDA: Profit/loss before net financial items, depreciations, write-downs and tax
Equity per share: Equity at the end of the period divided by the number of shares at the end of the period Quarterly earnings ratios are not disclosed
Operating costs (as described on pg 4): Operating costs excluding costs for products sold and excluding participations in associated companies, but including depreciation and write-downs and capitalization of costs for development work
Changes in equity, Group
(Figures in thousands SEK)
| Capital | Other paid in |
Reserves | Balanced profit/ |
Total | |
|---|---|---|---|---|---|
| stock | capital | year's profit | equity | ||
| Opening balance as at January 1, 2009 | 40,488 | 500,155 | -466 | -524,173 | 16,004 |
| Comprehensive income for the period | - | - | 621 | -21,772 | -21,151 |
| Transactions with the shareholders | |||||
| Stock option program1) | - | -77 | - | - | -77 |
| New share issue2) | 13,496 | 37,136 | - | - | 50,632 |
| Closing balance as at December 31, 2009 | 53,984 | 537,214 | 155 | -545,945 | 45,408 |
| Comprehensive income for the period | - | - | -580 | -5,078 | -5,658 |
| Closing balance as at June 30, 2010 | 53,984 | 537,214 | -425 | -551,023 | 39,750 |
1) Repurchase of 450,000 share options. 2)
New share issue totaling 33 740 200 new shares at a rate of SEK 1.60 with deductions for issue
costs SEK 3,352 thousand.
Turnover and profitability by Regions Q2 2010
| (Figures in thousands SEK) |
North America | Europe | Middle East & Africa |
Asia | ||||
|---|---|---|---|---|---|---|---|---|
| 2010 | 2009 | 2010 | 2009 | 2010 | 2009 | 2010 | 2009 | |
| Net sales | 3,771 | 4,075 | 2,456 | 2,377 | 92 | 3,306 | 830 | - |
| Expenses1) | -3,249 | -1,995 | -1,863 | -4,278 | -617 | -2,307 | -370 | -457 |
| Operating profit/loss | 522 | 2,080 | 593 | -1,901 | -525 | 999 | 460 | -457 |
| Latin America | Other | Total | ||||
|---|---|---|---|---|---|---|
| 2010 | 2009 | 2010 | 2009 | 2010 | 2009 | |
| Net sales | - | - | - | -11 | 7,149 | 9,747 |
| Expenses1) | - | - | -3 | - | -6,102 | -9,037 |
| Operating profit/loss | - | - | -3 | -11 | 1,047 | 710 |
Turnover and profitability by Regions Q1-Q2 2010
| (Figures in thousands SEK) |
North America | Europe | Middle East & Africa |
Asia | ||||
|---|---|---|---|---|---|---|---|---|
| 2010 | 2009 | 2010 | 2009 | 2010 | 2009 | 2010 | 2009 | |
| Net sales | 12,780 | 4,204 | 6,526 | 8,664 | 5,283 | 5,383 | 928 | 517 |
| Expenses1) | -8,375 | -2,574 | -3,960 | -8,320 | -4,098 | -3,468 | -319 | -1,253 |
| Operating profit/loss | 4,405 | 1,630 | 2,566 | 344 | 1,185 | 1,915 | 609 | -736 |
| Latin America | Other | Total | |||||
|---|---|---|---|---|---|---|---|
| 2010 | 2009 | 2010 | 2009 | 2010 | 2009 | ||
| Net sales | 912 | 3,175 | - | - | 26,429 | 21,943 | |
| Expenses1) | - | - | 231 | - | -16,521 | -15,615 | |
| Operating profit/loss | 912 | 3,175 | 231 | - | 9,908 | 6,328 |
1) The above expenses in Regions include Cost of goods sold as well as operation expenses for each region.
Income statement, Parent company
| (Figures in thousands SEK) | Q1-Q2 | Q1-Q2 | Full Year |
|---|---|---|---|
| 2010 | 2009 | 2009 | |
| Net sales | 22,544 | 16,752 | 57,397 |
| Cost of goods sold | -11,891 | -5,355 | -28,493 |
| Gross profit/loss | 10,653 | 11,397 | 28,904 |
| Selling expenses | -7,353 | -8,435 | -20,562 |
| Administrative expenses | -4,820 | -5,753 | -10,390 |
| R&D costs | -5,776 | -6,496 | -12,092 |
| Other operating income and changes in value | 4,020 | -4 | -3,174 |
| -13,929 | -20,688 | -46,218 | |
| Operating profit/loss | -3,276 | -9,291 | -17,314 |
| Financial costs1) | 136 | -70 | -6,507 |
| Profit/loss after financial items | -3,140 | -9,361 | -23,821 |
| Tax | - | - | - |
| Profit/loss for the period | -3,140 | -9,361 | -23,821 |
1) Include a write-down of the value in the subsidiary Precise Biometrics Solutions AB amounting SEK 5.5 million in 2009
Page 14 of 15
Lund, July 20, 2010
Balance Sheet, Parent company
| (Figures in thousands SEK) | 6/30/2010 | 6/30/2009 12/31/2009 | |
|---|---|---|---|
| Assets | |||
| Intangible fixed assets | 4,430 | 4,061 | 3,655 |
| Tangible fixed assets | 355 | 616 | 479 |
| Participations in group companies | 1,058 | 6,540 | 1,058 |
| Inventories | 4,578 | 5,987 | 6,047 |
| Accounts receivable - trade | 1,742 | 1,520 | 6,176 |
| Other current receivables | 41,857 | 42,478 | 54,865 |
| Cash and bank balances | 32,331 | 1,398 | 28,494 |
| Total assets | 86,351 | 62,600 | 100,774 |
| Equity and liabilities | |||
| Equity | 76,623 | 45,460 | 79,763 |
| Other provisions | 203 | 603 | 284 |
| Current liabilities | 9,525 | 16,537 | 20,727 |
| Total equity and liabilities | 86,351 | 62,600 | 100,774 |
| Pledged assets | 21,000 | 15,000 | 24,000 |
| Contingent liabilities | 2,000 | 2,000 | 2,000 |
Page 15 of 15
Lund, July 20, 2010
Telephone conference
On the occasion of today's Interim Report we have the pleasure to invite investors and journalists to the following informative meeting during the day
- The conference starts at 11:00 (CET)
- To participate, please call +46 (0)8 506 269 04 269 04
An operator will note your name and connect you to the conference. She/he will also provide you with information about what to do if you have any questions.
The presentation will be held in English but afterwards there will be an opportunity to ask questions in Swedish.
Participating on behalf of Precise Biometrics
- Thomas Marschall, President and CEO
- Patrik Norberg, CFO
A recording from the conference will be available for three days after the telephone meeting. To listen to the conference afterwards dial +46 (0)8 506 269 49. When asked to state a reference number please dial 245739 and finish with (#).
Please visit www.precisebiometrics.com/presentations where a presentation can be downloaded.
For further information
Thomas Marschall, President and CEO, Precise Biometrics Tel. +46 (0)46 31 11 10 or +46 (0)734 35 11 10 E-mail [email protected]
Patrik Norberg, CFO, Precise Biometrics AB Tel. +46 46 31 11 47 or +46 734 35 11 47 E-mail [email protected]
Precise Biometrics AB (Headquarters) Box 798 SE-220 07 Lund Tel.: +46 (0)46 31 11 00 Fax: +46 (0)46 31 11 01 E-mail: [email protected]
Precise Biometrics is a market-leading provider of products and solutions for fingerprint recognition. The technology proves people's identities in a fast and secure way, while it reduces costs related to password management, identity theft and fraud.
Precise Biometrics serves business and government organizations throughout the world and its technology is licensed to close to 100 million users. Precise Biometrics is listed on NASDAQ OMX Stockholm small cap list (PREC).
For more information, please visit www.precisebiometrics.com or view the Company presentation.